Zoetis Inc.
NYSE: ZTS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Kristin C. Peck
- Employees
- 13,800
- Headquarters
- Parsippany, United States
- IPO year
- 2013
- Market cap
- $33.0B
- Website
- https://www.zoetis.com
Loading ZTS…
Loading profile data…Frequently asked questions about ZTS
What does Zoetis Inc. (ZTS) do?
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and belo...
Where does ZTS trade?
Zoetis Inc. (ZTS) trades on the New York Stock Exchange.
What sector is ZTS in?
Zoetis Inc. (ZTS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Zoetis Inc.?
Kristin C. Peck is the chief executive officer of Zoetis Inc. (ZTS).
Where is Zoetis Inc. headquartered?
Zoetis Inc. is headquartered in United States.
Does ZTS pay a dividend?
Yes — Zoetis Inc. (ZTS) paid a trailing twelve-month dividend of USD 2.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ZTS go public?
Zoetis Inc. (ZTS) completed its initial public offering in 2013.